Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Clinical trial NCT02096263 · COMPLETED

Trial details

NCT number: NCT02096263
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Poliomyelitis Diphtheria Haemophilus Influenzae Type b Tetanus Acellular Pertussis Hepatitis B

Start date: 2014-04-16
Primary completion: 2015-02-06
Enrollment: 585

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.